Nonconvulsive status epilepticus related to posterior reversible leukoencephalopathy syndrome induced by cetuximab

Neurologist

Volumn 17, Issue 5, 2011, Pages 273-275

  Palma, Jose Alberto ^a   Gomez Ibañez, Asier ^a   Martin, Beatriz ^a   Urrestarazu, Elena ^a   Gil Bazo, Ignacio ^a   Pastor, Maria A ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

cetuximab; chemotherapy; EGFR; nonconvulsive status epilepticus; posterior reversible leukoencephalopathy syndrome

Indexed keywords

CETUXIMAB; CISPLATIN; CLONAZEPAM; ETIRACETAM; PACLITAXEL; PROPOFOL; VALPROIC ACID;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BILATERAL INGUINAL LYMPHADENECTOMY; BLINDNESS; BLOOD PRESSURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FOLLOW UP; GRAND MAL SEIZURE; HEADACHE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; INTUBATION; MALE; MENTAL DEFICIENCY; METASTATIC SQUAMOUS CELL CARCINOMA OF THE PENIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUROLOGIC EXAMINATION; NONCONVULSIVE EPILEPTIC STATE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PENIS AMPUTATION; PENIS CANCER; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; STUPOR; SURGICAL TECHNIQUE; TREATMENT DURATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PENILE NEOPLASMS; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; STATUS EPILEPTICUS;

EID: 80052611606     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e3182173655     Document Type: Article

References (19)

1. Bhatt A, Farooq MU, Majid A, et al. Chemotherapy-related posterior reversible leukoencephalopathy syndrome. Nat Clin Pract Neurol. 2009;5:163-169.
2. Kastrup O, Maschke M, Wanke I, et al. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol. 2002;249:1563-1566. (Pubitemid 35477899)
3. Utz N, Kinkel B, Hedde JP, et al. MR imaging of acute intermittent porphyria mimicking reversible posterior leukoencephalopathy syndrome. Neuroradiology. 2001;43:1059-1062. (Pubitemid 33133644)
4. Takeuchi S, Takasto Y, Homma M. Reversible posterior leukoencephalopathy syndrome caused by hanging. J Neurol Neurosurg Psychiatry. 2009;80:908-909.
5. Shah-Khan FM, Pinedo D, Shah P. Reversible posterior leukoencephalopathy syndrome and anti-neoplastic agents: a review. Oncol Rev. 2007;1:152-161.
6. Martin G, Bellido L, Cruz JJ. Reversible posterior leukoencephalopathy syndrome induced by sunitinib. J Clin Oncol. 2007;25: 3559. (Pubitemid 47310905)
7. Govindarajan R, Adusumilli J, Baxter DL, et al. Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006. J Clin Oncol. 2006;24:48.
8. Kastrup O, Diener HC. TNF-antagonist etanercept induced reversible posterior leukoencephalopathy syndrome. J Neurol. 2008; 255:452-453.
9. Kelly K, Kalachand R, Murphy P. Bortezomib-induced reversible posterior leucoencephalopathy syndrome. Br J Haematol. 2008;141:566. (Pubitemid 351667623)
10. Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med. 2006;354: 980-981.
11. Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29:1036-1042. (Pubitemid 351954863)
12. Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29:1043-1049. (Pubitemid 351954864)
13. Kozak OS, Wijdicks EF, Manno EM, et al. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology. 2007;69:894-897. (Pubitemid 47329589)
14. Ahn KJ, You WJ, Jeong SL, et al. Atypical manifestations of reversible posterior leukoencephalopathy syndrome. Neuroradiology. 2004;46:978-983.
15. Lee VH, Fijdicks EFM, Manno EM, et al. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65:205-210. (Pubitemid 351240781)
16. Chowdhary S, Chamberlain MC. Neuroradiographic variant of posterior reversible leukoencephalopathy. J Neurooncol. 2007;82: 111-112.
17. Decker DA, Falchook AD, Yachnis AT, et al. Radiographic and pathologic findings in an atypical brainstem variant of reversible posterior leukoencephalopathy syndrome. Neurologist. 2009;15: 364-366.
18. Abbas AK. Immunity to tumors. In: Abbas AK, Lichtman AH, eds. Cellular and Molecular Immunology. 5th ed. Philadelphia: Elsevier Saunders; 2005:391-410.
19. Vaughn C, Zhang L, Schiff D. Reversible posterior leukoencephalopathy syndrome in cancer. Curr Oncol Rep. 2008;10:86-91.